Subscribe
Logo small
Search
banner

AOTMiT: There is the first list of cardiovascular drugs without reimbursement claims

MedExpress Team

medexpress.pl

Published June 14, 2024 09:16

AOTMiT: There is the first list of cardiovascular drugs without reimbursement claims - Header image
Fot. Getty Images/iStockphoto
AOTMiT has completed work on developing a list concerning drugs for cardiovascular indications, requiring use longer than 30 days for a specific clinical condition and recommended in clinical management guidelines, for which the applicant has not yet submitted an application for reimbursement and setting the official sales price in the indications, and market exclusivity has expired.

The June 10, 2024 list included 21 active substances.

The creation of the list, is the first stage of the reimbursement process. The prepared list will become the basis for further work on the reimbursement of drug technologies included in the list.

The next step is for the Minister of Health to create a list of drugs on the basis of the list, after consulting with the Transparency Council, national consultants in the relevant medical field and the Patient Ombudsman.

Subsequently, the Minister of Health informs the responsible entities whose drugs are on this list of the possibility of submitting an application for reimbursement coverage, as referred to in Article 24(1)(1) of the...

Content locked

To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].

If you already have an account, please log in

Szukaj nowych pracowników

Dodaj ogłoszenie już za 4 zł dziennie*.

* 4 zł netto dziennie. Minimalny okres ekspozycji ogłoszenia to 30 dni.